サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：デュピュイトラン拘縮市場：タイプ別、疾患タイプ別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
市場調査レポート
商品コード
1419084

デュピュイトラン拘縮市場：タイプ別、疾患タイプ別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測

Dupuytren's Disease Market, By Type, By Disease Type, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

出版日
ページ情報
英文 303 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
デュピュイトラン拘縮市場：タイプ別、疾患タイプ別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
出版日: 2024年01月01日
発行: AnalystView Market Insights
ページ情報: 英文 303 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

2022年のデュピュイトラン拘縮市場規模は41億3,100万米ドルで、2023年から2030年にかけてCAGR 4.44%で拡大する見込みです。

デュピュイトラン拘縮市場-市場力学

医療研究開発と疾病の蔓延が市場需要を促進

この疾患の罹患率の上昇が、市場の顕著な拡大に拍車をかけています。Journal of Hand Surgery誌に発表された最近の研究で、診断症例が顕著に増加していることが証明されているように、治療の選択肢を必要とする患者が増加しています。効率的な管理技術への需要に対応するため、製薬企業や医療機器メーカーは研究開発への支出を拡大しています。さらに、米国で2021年に実施された人口調査によると、最大7％の人が臨床症状を有し、その3分の1以上がデュプイトレン拘縮の影響を受けています。

さらに、医療における技術的・科学的開拓が進んでいることも市場開拓に寄与しています。利害関係者は、業界が成長するにつれ、患者の変化する要求に対応し、疾病管理の結果を改善する可能性を持っています。Journal of Hand Surgery誌は、デュピュイトラン拘縮を治療するためのより多くの非外科的方法の必要性を強調し、新しい治療法や技術に関する手外科医間の継続的な対話を奨励しています。

デュピュイトラン拘縮市場-セグメンテーション分析：

デュピュイトラン拘縮の世界市場は、タイプ、疾患タイプ、エンドユーザー、地域に基づいてセグメント化されます。

市場はタイプ別に診断と治療の2つに分類されます。治療分野が市場を独占しています。製薬会社は、疾患治療のための革新的な治療ソリューションの開発に注力しています。

市場は疾患タイプ別に、I型、II型、III型の3つに分類されます。II型セグメントは市場を独占しており、予測期間中もその優位性を維持するとみられます。デジタルコード障害を伴う疾患の有病率の増加が市場成長を後押しするとみられます。

市場はエンドユーザー別に病院、診療所、研究機関、その他の4つに分類されます。病院分野は市場を独占しており、予測期間中もその優位性を維持するとみられます。病院は全人的な治療ケアを提供しており、市場の成長を後押しすると期待されています。

デュピュイトラン拘縮市場-地理的洞察

地理的に、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東およびアフリカの地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。

デュピュイトラン拘縮市場-競合情勢：

患者数の増加、治療法の改善、認知度の向上により、市場は大きく拡大しています。主要プレイヤーは、専門的なケアと効率的な治療法を提供することで、これらの機会を活用することができます。業界シェアを拡大するため、市場参入企業は合併、買収、提携などの戦略的活動に絶えず参加しています。例えば、2022年4月、180 Life Sciences社とオックスフォード大学は、デュプイトレン症に対するポジティブな第2b相試験結果の公表を発表しました。

目次

第1章 デュピュイトラン拘縮市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 デュピュイトラン拘縮の主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 デュピュイトラン拘縮産業調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 デュピュイトラン拘縮市場：COVID-19の影響分析

  • COVID-19前の影響分析
  • COVID-19後の影響分析

第6章 デュピュイトラン拘縮の市場情勢

  • デュピュイトラン拘縮市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 デュピュイトラン拘縮市場：タイプ別

  • 概要
    • タイプ別セグメントシェア分析
    • 診断
    • 治療

第8章 デュピュイトラン拘縮市場：疾患タイプ別

  • 概要
    • 疾患別セグメントシェア分析
    • タイプI
    • タイプⅡ
    • タイプⅢ

第9章 デュピュイトラン拘縮市場：エンドユーザー別

  • 概要
    • エンドユーザー別のセグメントシェア分析
    • 病院
    • クリニック
    • 研究機関
    • その他

第10章 デュピュイトラン拘縮市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- デュピュイトラン拘縮業界

  • 競合ダッシュボード
  • 企業プロファイル
    • BASF SE
    • Bayer AG
    • Novartis AG
    • Pfizer Inc.
    • Nantong Jinghua Pharmaceutical Co., Ltd.
    • Actiza Pharmaceutical Private Limited
    • Endo International plc
    • Bristol-Meyers Squibb Company
    • Spear Pharmaceuticals
    • Fresenius Kabi AG
    • GSK plc
    • AstraZeneca
    • Hikma Pharmaceuticals PLC
    • LEO Pharma A/S
    • Others

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Dupuytren's Disease Market: Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Dupuytren's Disease Market, by Type 2018-2030 (USD Million)
  • TABLE Dupuytren's Disease Market: Disease Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Disease Type
  • TABLE Global Dupuytren's Disease Market, by Disease Type 2018-2030 (USD Million)
  • TABLE Dupuytren's Disease Market: End-User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Dupuytren's Disease Market, by End-User 2018-2030 (USD Million)
  • TABLE Dupuytren's Disease Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Dupuytren's Disease Market, by Region 2018-2030 (USD Million)
  • TABLE North America Dupuytren's Disease Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Dupuytren's Disease Market, by Type, 2018-2030 (USD Million)
  • TABLE North America Dupuytren's Disease Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE North America Dupuytren's Disease Market, by End-User, 2018-2030 (USD Million)
  • TABLE Europe Dupuytren's Disease Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Dupuytren's Disease Market, by Type, 2018-2030 (USD Million)
  • TABLE Europe Dupuytren's Disease Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Europe Dupuytren's Disease Market, by End-User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Dupuytren's Disease Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Dupuytren's Disease Market, by Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Dupuytren's Disease Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Dupuytren's Disease Market, by End-User, 2018-2030 (USD Million)
  • TABLE Latin America Dupuytren's Disease Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Dupuytren's Disease Market, by Type, 2018-2030 (USD Million)
  • TABLE Latin America Dupuytren's Disease Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Latin America Dupuytren's Disease Market, by End-User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Dupuytren's Disease Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Dupuytren's Disease Market, by Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Dupuytren's Disease Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Dupuytren's Disease Market, by End-User, 2018-2030 (USD Million)
目次
Product Code: ANV2149

REPORT HIGHLIGHT

Dupuytren's Disease Market size was valued at USD 4,131.00 Million in 2022, expanding at a CAGR of 4.44% from 2023 to 2030.

Dupuytren's disease causes Fascia, a layer of tissue beneath the skin, thickens abnormally in the palm of your hand near the base of your fingers. This enlarged region could turn into a thick band or hard lump.

Dupuytren's Disease Market- Market Dynamics

Increasing developments in medical research & technology and prevalence of disease to propel market demand

The rising incidence of the illness is fueling the market's notable expansion. A growing number of patients need treatment choices, as evidenced by a recent study that was published in the Journal of Hand Surgery and showed a noticeable increase in diagnosed cases. To address the demand for efficient management techniques, pharmaceutical businesses and makers of medical devices have expanded their spending in research and development. Furthermore, according to a population survey conducted in the United States in 2021, up to 7% of people have clinical symptoms, and over one-third of those people are impacted by Dupuytren's contractures.

Furthermore, the growing number of technological and scientific developments in medicine also contributing to market growth. Stakeholders have potential to address patients' changing requirements and improve illness management results as the industry grows. The Journal of Hand Surgery highlights the need for more nonsurgical methods to treat Dupuytren's disease and encourages continuous dialogue among hand surgeons about new treatments and techniques.

Dupuytren's Disease Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.44% over the forecast period (2023-2030)
  • Based on Type segmentation, treatment segment was predicted to show maximum market share in the year 2022, owing to high focus on developing treatment options.
  • Based on Disease Type segmentation, disease type II segment was the leading segment in 2022, mainly characterized palmer fascia.
  • Based on End-User segmentation, hospitals segment was the leading segment in 2022, mainly due to increasing development healthcare facilities.
  • On the basis of region, North America was the leading revenue generator in 2022, owing to high prevalence of Dupuytren disease.

Dupuytren's Disease Market- Segmentation Analysis:

The Global Dupuytren's Disease Market is segmented on the basis of Type, Disease Type, End-User, and Region.

The market is divided into two categories based on Type: diagnosis and treatment. The treatment segment dominates the market. Pharmaceutical companies are focusing on developing innovative treatment solutions for treatment of disease.

The market is divided into three categories based on Disease Type: Type I, Type II, and Type III. The Type II segment dominates the market and is likely to maintain its dominance during the forecast period. The growing prevalence of disease with digital cords impairment are likely to boost market growth.

The market is divided into four categories based on End-User: hospitals, clinics, research institutes, and others. The hospitals segment dominates the market and is likely to maintain its dominance during the forecast period. Hospitals provide holistic care treatment care and is expected to boost the market growth.

Dupuytren's Disease Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Dupuytren's Disease Market- Competitive Landscape:

The market is expanding significantly because of rising patient numbers, improved treatment, and more awareness. Major players can take advantage of these opportunities by providing specialized care and efficient therapies. To increase their industry share, market players are constantly taking part in strategic activities including mergers, acquisitions, and partnerships. For example, in April 2022, 180 Life Sciences and the University of Oxford announced the publication of positive Phase 2b study results for Dupuytren's.

Recent Developments:

In April 2023, a newly launched specialty pharmaceutical company called Ventoux Biosciences, which is dedicated to transforming the management of fibrotic diseases, including Dupuytren's disease.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DUPUYTREN'S DISEASE MARKET KEY PLAYERS

  • BASF SE
  • Bayer AG
  • Novartis AG
  • Pfizer Inc.
  • Nantong Jinghua Pharmaceutical Co., Ltd.
  • Actiza Pharmaceutical Private Limited
  • Endo International plc
  • Bristol-Meyers Squibb Company
  • Spear Pharmaceuticals
  • Fresenius Kabi AG
  • GSK plc
  • AstraZeneca
  • Hikma Pharmaceuticals PLC
  • LEO Pharma A/S
  • Others

GLOBAL DUPUYTREN'S DISEASE MARKET, BY TYPE

  • Diagnosis
  • Treatment

GLOBAL DUPUYTREN'S DISEASE MARKET, BY DISEASE TYPE

  • Type I
  • Type II
  • Type III

GLOBAL DUPUYTREN'S DISEASE MARKET, BY END-USER

  • Hospitals
  • Clinics
  • Research Institutes
  • Others

GLOBAL DUPUYTREN'S DISEASE MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Dupuytren's Disease Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Dupuytren's Disease Market Snippet by Type
    • 2.1.2. Dupuytren's Disease Market Snippet by Disease Type
    • 2.1.3. Dupuytren's Disease Market Snippet by End-User
    • 2.1.4. Dupuytren's Disease Market Snippet by Country
    • 2.1.5. Dupuytren's Disease Market Snippet by Region
  • 2.2. Competitive Insights

3. Dupuytren's Disease Key Market Trends

  • 3.1. Dupuytren's Disease Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Dupuytren's Disease Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Dupuytren's Disease Market Opportunities
  • 3.4. Dupuytren's Disease Market Future Trends

4. Dupuytren's Disease Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Dupuytren's Disease Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Dupuytren's Disease Market Landscape

  • 6.1. Dupuytren's Disease Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Dupuytren's Disease Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
    • 7.1.2. Diagnosis
    • 7.1.3. Treatment

8. Dupuytren's Disease Market - By Disease Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Disease Type, 2022 & 2030 (%)
    • 8.1.2. Type I
    • 8.1.3. Type II
    • 8.1.4. Type III

9. Dupuytren's Disease Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2022 & 2030 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Clinics
    • 9.1.4. Research Institutes
    • 9.1.5. Others

10. Dupuytren's Disease Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Dupuytren's Disease Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Dupuytren's Disease Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Dupuytren's Disease Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Dupuytren's Disease Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Dupuytren's Disease Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Dupuytren's Disease Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. BASF SE
    • 11.2.2. Bayer AG
    • 11.2.3. Novartis AG
    • 11.2.4. Pfizer Inc.
    • 11.2.5. Nantong Jinghua Pharmaceutical Co., Ltd.
    • 11.2.6. Actiza Pharmaceutical Private Limited
    • 11.2.7. Endo International plc
    • 11.2.8. Bristol-Meyers Squibb Company
    • 11.2.9. Spear Pharmaceuticals
    • 11.2.10. Fresenius Kabi AG
    • 11.2.11. GSK plc
    • 11.2.12. AstraZeneca
    • 11.2.13. Hikma Pharmaceuticals PLC
    • 11.2.14. LEO Pharma A/S
    • 11.2.15. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us